BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: White RR, Avital I, Sofocleous CT, Brown KT, Brody LA, Covey A, Getrajdman GI, Jarnagin WR, Dematteo RP, Fong Y. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg. 2007;11:256-263. [PMID: 17458595 DOI: 10.1007/s11605-007-0100-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Peng S, Huang P, Yu H, Wen Y, Luo Y, Wang X, Zhou J, Qin S, Li T, Chen Y, Liu G, Huang M. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. Medicine (Baltimore) 2018;97:e0044. [PMID: 29517661 DOI: 10.1097/MD.0000000000010044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Helmberger T. [Interventional procedures for hepatic metastases]. Chirurg. 2010;81:542-550. [PMID: 20502849 DOI: 10.1007/s00104-010-1888-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kim M, Son SH, Won YK, Kay CS. Stereotactic ablative radiotherapy for oligometastatic disease in liver. Biomed Res Int 2014;2014:340478. [PMID: 24868526 DOI: 10.1155/2014/340478] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Procopio F, Marano S, Gentile D, Da Roit A, Basato S, Riva P, De Vita F, Torzilli G, Castoro C. Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments. Cancers (Basel) 2019;12:E20. [PMID: 31861604 DOI: 10.3390/cancers12010020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Buell JF, Thomas MT, Rudich S, Marvin M, Nagubandi R, Ravindra KV, Brock G, McMasters KM. Experience with more than 500 minimally invasive hepatic procedures. Ann Surg. 2008;248:475-486. [PMID: 18791368 DOI: 10.1097/sla.0b013e318185e647] [Cited by in Crossref: 76] [Cited by in F6Publishing: 102] [Article Influence: 5.4] [Reference Citation Analysis]
6 Katayose Y, Unno M. Management of liver metastases from colorectal cancer. Clin J Gastroenterol 2010;3:128-35. [PMID: 26190118 DOI: 10.1007/s12328-010-0155-z] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, Quan Z, Gong W. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7:e45493. [PMID: 23029051 DOI: 10.1371/journal.pone.0045493] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
8 Sofocleous CT, Garg S, Petrovic LM, Gonen M, Petre EN, Klimstra DS, Solomon SB, Brown KT, Brody LA, Covey AM. Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol. 2012;19:4262-4269. [PMID: 22752375 DOI: 10.1245/s10434-012-2461-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
9 Shi Y, Wang Z, Chi J, Shi D, Wang T, Cui D, Lin Y, Zhai B. Long-term results of percutaneous microwave ablation for colorectal liver metastases. HPB (Oxford) 2021;23:37-45. [PMID: 32561175 DOI: 10.1016/j.hpb.2020.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nam J, Shin J, Kim K, Park J, Kim W, Choi C, Choi Y, Hong K. Clinical Significance of Serum Carcinoembryonic Antigen (CEA) Level at Diagnosis of Liver Metastases in Patients with Colorectal Cancer. J Korean Soc Coloproctol 2008;24:439. [DOI: 10.3393/jksc.2008.24.6.439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Li D, Kang J, Golas BJ, Yeung VW, Madoff DC. Minimally invasive local therapies for liver cancer. Cancer Biol Med. 2014;11:217-236. [PMID: 25610708 DOI: 10.7497/j.issn.2095-3941.2014.04.001] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
12 Yang S, Alibhai SM, Kennedy ED, El-Sedfy A, Dixon M, Coburn N, Kiss A, Law CH. Optimal management of colorectal liver metastases in older patients: a decision analysis. HPB (Oxford) 2014;16:1031-42. [PMID: 24961482 DOI: 10.1111/hpb.12292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Jin M, Yu Q, Liu Y, Xu W, Fu X, Ji B. Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis. J Clin Transl Hepatol 2021;9:149-59. [PMID: 34007796 DOI: 10.14218/JCTH.2020.00125] [Reference Citation Analysis]
14 Agcaoglu O, Aliyev S, Karabulut K, El-Gazzaz G, Aucejo F, Pelley R, Siperstein AE, Berber E. Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg 2013;37:1333-9. [PMID: 23460452 DOI: 10.1007/s00268-013-1981-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
15 Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 2013;7:1-6. [PMID: 23422905 DOI: 10.5009/gnl.2013.7.1.1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
16 Chen C, Liang C, Lu C, Liu Y, Lu S, Hung C. Prognostic factors of radiofrequency ablation therapy for liver metastases from colorectal cancer. Adv in Digestive Med 2019;6:101-8. [DOI: 10.1002/aid2.13123] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Doyle MBM, Chapman WC. Radiofrequency Ablation for Resectable Colorectal Hepatic Metastases: Is It Time for a Randomized Controlled Trial? Annals of Surgery 2010;251:804-6. [DOI: 10.1097/sla.0b013e3181dbb1f8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Eltawil KM, Boame N, Mimeault R, Shabana W, Balaa FK, Jonker DJ, Asmis TR, Martel G. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases. J Surg Oncol. 2014;110:734-738. [PMID: 24965163 DOI: 10.1002/jso.23689] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
19 Brouquet A, Andreou A, Vauthey JN. The management of solitary colorectal liver metastases. Surgeon 2011;9:265-72. [PMID: 21843821 DOI: 10.1016/j.surge.2010.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
20 Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg. 2008;12:1967-1972. [PMID: 18688683 DOI: 10.1007/s11605-008-0622-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
21 Stang A, Fischbach R, Teichmann W, Bokemeyer C, Braumann D. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer. 2009;45:1748-1756. [PMID: 19356924 DOI: 10.1016/j.ejca.2009.03.012] [Cited by in Crossref: 100] [Cited by in F6Publishing: 84] [Article Influence: 7.7] [Reference Citation Analysis]
22 Sotirchos VS, Petrovic LM, Gönen M, Klimstra DS, Do RK, Petre EN, Garcia AR, Barlas A, Erinjeri JP, Brown KT, Covey AM, Alago W, Brody LA, DeMatteo RP, Kemeny NE, Solomon SB, Manova-Todorova KO, Sofocleous CT. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome. Radiology 2016;280:949-59. [PMID: 27010254 DOI: 10.1148/radiol.2016151005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 10.7] [Reference Citation Analysis]
23 Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, Noya G, Abraha I. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317. [PMID: 22696357 DOI: 10.1002/14651858.cd006317.pub3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
24 Yamakado K, Inaba Y, Sato Y, Yasumoto T, Hayashi S, Yamanaka T, Nobata K, Takaki H, Nakatsuka A. Radiofrequency Ablation Combined with Hepatic Arterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Liver Metastasis from Colorectal Cancer: A Prospective Multicenter Study. Cardiovasc Intervent Radiol. 2017;40:560-567. [PMID: 27999917 DOI: 10.1007/s00270-016-1547-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Yang PC, Lin BR, Chen YC, Lin YL, Lai HS, Huang KW, Liang JT. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer. Medicine (Baltimore) 2016;95:e3338. [PMID: 27057913 DOI: 10.1097/MD.0000000000003338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
26 Kurbatov V, Resio BJ, Cama CA, Heller DR, Cha C, Zhang Y, Lu J, Khan SA. Liver-first approach to stage IV colon cancer with synchronous isolated liver metastases. J Gastrointest Oncol 2020;11:76-83. [PMID: 32175108 DOI: 10.21037/jgo.2020.01.03] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Hao W, Binbin J, Wei Y, Kun Y. Can Radiofrequency Ablation Replace Liver Resection for Solitary Colorectal Liver Metastasis? A Systemic Review and Meta-Analysis. Front Oncol 2020;10:561669. [PMID: 33312946 DOI: 10.3389/fonc.2020.561669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Park BJ, Byun JH, Jin YH, Won HJ, Shin YM, Kim KW, Park SJ, Kim PN. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol. 2009;20:490-499. [PMID: 19328427 DOI: 10.1016/j.jvir.2009.01.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
29 Takeda A, Sanuki N, Kunieda E. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer. World J Gastroenterol 2014; 20(15): 4220-4229 [PMID: 24764660 DOI: 10.3748/wjg.v20.i15.4220] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
30 Yoon HM, Kim JH, Shin YM, Won HJ, Kim PN. Percutaneous radiofrequency ablation using internally cooled wet electrodes for treatment of colorectal liver metastases. Clin Radiol. 2012;67:122-127. [PMID: 21906730 DOI: 10.1016/j.crad.2011.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
31 Sotirchos VS, Fujisawa S, Vakiani E, Solomon SB, Manova-Todorova KO, Sofocleous CT. Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation. Ann Surg Oncol 2019;26:1833-40. [PMID: 30830537 DOI: 10.1245/s10434-018-07133-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
32 Han Y, Yan D, Xu F, Li X, Cai JQ. Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis. Chin Med J (Engl) 2016;129:2983-90. [PMID: 27958231 DOI: 10.4103/0366-6999.195470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
33 Gavriilidis P, Roberts KJ, de'Angelis N, Aldrighetti L, Sutcliffe RP. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis. Hepatobiliary Pancreat Dis Int 2021;20:307-14. [PMID: 34127382 DOI: 10.1016/j.hbpd.2021.05.004] [Reference Citation Analysis]
34 Wu YZ, Li B, Wang T, Wang SJ, Zhou YM. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: A meta-analysis. World J Gastroenterol 2011; 17(36): 4143-4148 [PMID: 22039331 DOI: 10.3748/wjg.v17.i36.4143] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
35 Chiappa A, Makuuchi M, Lygidakis NJ, Zbar AP, Chong G, Bertani E, Sitzler PJ, Biffi R, Pace U, Bianchi PP. The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy. Crit Rev Oncol Hematol. 2009;72:65-75. [PMID: 19147371 DOI: 10.1016/j.critrevonc.2008.11.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
36 Rocha FG, D’Angelica M. Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation. J Surg Oncol. 2010;102:968-974. [PMID: 21166000 DOI: 10.1002/jso.21720] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
37 Knab LM, Salem R, Mahvi DM. Minimally invasive therapies for hepatic malignancy. Curr Probl Surg 2013;50:146-79. [PMID: 23507316 DOI: 10.1067/j.cpsurg.2013.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
38 Milano MT, Katz AW, Okunieff P. Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ. Am J Clin Oncol 2010;33:157-63. [PMID: 19770627 DOI: 10.1097/COC.0b013e3181979238] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
39 Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 2012;23:153-63. [PMID: 22264550 DOI: 10.1016/j.jvir.2011.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
40 Wild AT, Yamada Y. Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer. Visc Med 2017;33:54-61. [PMID: 28612018 DOI: 10.1159/000454685] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
41 Johnson EE, Yamane BH, Buhtoiarov IN, Lum HD, Rakhmilevich AL, Mahvi DM, Gillies SD, Sondel PM. Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma. Clin Cancer Res 2009;15:4875-84. [PMID: 19638464 DOI: 10.1158/1078-0432.CCR-09-0110] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
42 Lanuti M, Sharma A, Digumarthy SR, Wright CD, Donahue DM, Wain JC, Mathisen DJ, Shepard JO. Radiofrequency ablation for treatment of medically inoperable stage I non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2009;137:160-6. [DOI: 10.1016/j.jtcvs.2008.08.034] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 8.1] [Reference Citation Analysis]
43 Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am 2015;24:97-119. [PMID: 25444471 DOI: 10.1016/j.soc.2014.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
44 Govaert KM, van Kessel CS, Steller EJ, Emmink BL, Molenaar IQ, Kranenburg O, van Hillegersberg R, Borel Rinkes IH. Recurrence location after resection of colorectal liver metastases influences prognosis. J Gastrointest Surg 2014;18:952-60. [PMID: 24474631 DOI: 10.1007/s11605-014-2461-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
45 Govindarajan A, Arnaoutakis D, D'Angelica M, Allen PJ, DeMatteo RP, Blumgart LH, Jarnagin WR, Fong Y. Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases. J Gastrointest Surg 2011;15:1168-72. [PMID: 21557021 DOI: 10.1007/s11605-011-1470-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
46 Sofocleous CT, Petre EN, Gonen M, Brown KT, Solomon SB, Covey AM, Alago W, Brody LA, Thornton RH, D'Angelica M, Fong Y, Kemeny NE. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22:755-761. [PMID: 21514841 DOI: 10.1016/j.jvir.2011.01.451] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
47 Lee H, Heo JS, Cho YB, Yun SH, Kim HC, Lee WY, Choi SH, Choi DW. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: A propensity score analysis. World J Gastroenterol 2015; 21(11): 3300-3307 [PMID: 25805937 DOI: 10.3748/wjg.v21.i11.3300] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
48 Ko S, Jo H, Yun S, Park E, Kim S, Seo HI. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol 2014; 20(2): 525-531 [PMID: 24574721 DOI: 10.3748/wjg.v20.i2.525] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
49 de Baere T. Traitement des métastases hépatiques par radiofréquence. Cancer/Radiothérapie 2012;16:339-43. [DOI: 10.1016/j.canrad.2012.05.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
50 Kron P, Linecker M, Jones RP, Toogood GJ, Clavien PA, Lodge JPA. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature. Front Oncol. 2019;9:1052. [PMID: 31750233 DOI: 10.3389/fonc.2019.01052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
51 Gravante G, Overton J, Sorge R, Bhardwaj N, Metcalfe MS, Lloyd DM, Dennison AR. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg. 2011;15:378-387. [PMID: 21061179 DOI: 10.1007/s11605-010-1377-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
52 Schullian P, Johnston EW, Putzer D, Laimer G, Waroschitz G, Braunwarth E, Amann A, Maglione M, Bale R. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection. Eur J Surg Oncol 2021;47:866-73. [PMID: 33032865 DOI: 10.1016/j.ejso.2020.09.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
53 Vietti Violi N, Duran R, Demartines N, Sempoux C, Guiu B, Bize PE, Sala N, Halkic N, Knebel JF, Denys A. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation. Int J Hyperthermia. 2018;34:1020-1028. [PMID: 29506424 DOI: 10.1080/02656736.2017.1372644] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
54 Gunvén P, Jonas E, Wersäll P, Lax I. Surgical displacement of risk organs to improve stereotactic radiotherapy for liver tumors. J Surg Oncol 2009;100:515-7. [PMID: 19653246 DOI: 10.1002/jso.21366] [Reference Citation Analysis]
55 Cassera MA, Potter KW, Ujiki MB, Swanström LL, Hansen PD. Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs. Surg Endosc 2011;25:1088-95. [DOI: 10.1007/s00464-010-1322-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
56 Fong Y, Wong J. Evolution in surgery: influence of minimally invasive approaches on the hepatobiliary surgeon. Surg Infect (Larchmt) 2009;10:399-406. [PMID: 19943774 DOI: 10.1089/sur.2009.9936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
57 Howard JH, Tzeng CD, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ. Radiofrequency Ablation for Unresectable Tumors of the Liver. The American Surgeon 2008;74:594-601. [DOI: 10.1177/000313480807400705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
58 Page AJ, Cosgrove D, Pawlik TM. Comparative effectiveness in hepatic malignancies. Cancer Treat Res 2015;164:195-219. [PMID: 25677025 DOI: 10.1007/978-3-319-12553-4_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Bennett S, Søreide K, Gholami S, Pessaux P, Teh C, Segelov E, Kennecke H, Prenen H, Myrehaug S, Callegaro D, Hallet J. Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic. Curr Oncol 2020;27:e501-11. [PMID: 33173390 DOI: 10.3747/co.27.6785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
60 Yang G, Wang G, Sun J, Xiong Y, Li W, Tang T, Li J. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies. Int J Surg 2021;87:105896. [PMID: 33588125 DOI: 10.1016/j.ijsu.2021.105896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Kingham TP, Tanoue M, Eaton A, Rocha FG, Do R, Allen P, De Matteo RP, D'Angelica M, Fong Y, Jarnagin WR. Patterns of recurrence after ablation of colorectal cancer liver metastases. Ann Surg Oncol. 2012;19:834-841. [PMID: 21879262 DOI: 10.1245/s10434-011-2048-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
62 Sofocleous CT, Nascimento RG, Petrovic LM, Klimstra DS, Gonen M, Brown KT, Brody LA, Covey AM, Thornton RH, Fong Y, Solomon SB, Schwartz LH, DeMatteo RP, Getrajdman GI. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 2008;249:364-74. [PMID: 18796687 DOI: 10.1148/radiol.2491071752] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
63 Cornelis FH, Petre EN, Vakiani E, Klimstra D, Durack JC, Gonen M, Osborne J, Solomon SB, Sofocleous CT. Immediate Postablation 18F-FDG Injection and Corresponding SUV Are Surrogate Biomarkers of Local Tumor Progression After Thermal Ablation of Colorectal Carcinoma Liver Metastases. J Nucl Med 2018;59:1360-5. [PMID: 29439012 DOI: 10.2967/jnumed.117.194506] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
64 Li D, Kang J, Madoff DC. Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther. 2014;14:931-945. [PMID: 24746315 DOI: 10.1586/14737140.2014.911091] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
65 Peacock O, Lee AC, Larvin M, Tufarelli C, Lund JN. MicroRNAs: relevant tools for a colorectal surgeon? World J Surg. 2012;36:1881-1892. [PMID: 22526047 DOI: 10.1007/s00268-012-1603-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
66 Otto G, Düber C, Hoppe-Lotichius M, König J, Heise M, Pitton MB. Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery. Ann Surg. 2010;251:796-803. [PMID: 19858704 DOI: 10.1097/sla.0b013e3181bc9fae] [Cited by in Crossref: 88] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
67 Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol. 2014;5:374-387. [PMID: 25276410 DOI: 10.3978/j.issn.2078-6891.2014.064] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
68 He N, Jin QN, Wang D, Yang YM, Liu YL, Wang GB, Tao KX. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technolog Med Sci. 2016;36:514-518. [PMID: 27465325 DOI: 10.1007/s11596-016-1617-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
69 Gillams A, Goldberg N, Ahmed M, Bale R, Breen D, Callstrom M, Chen MH, Choi BI, de Baere T, Dupuy D. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013. Eur Radiol. 2015;25:3438-3454. [PMID: 25994193 DOI: 10.1007/s00330-015-3779-z] [Cited by in Crossref: 138] [Cited by in F6Publishing: 130] [Article Influence: 19.7] [Reference Citation Analysis]
70 Gillams AR, Lees WR. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol. 2008;19:712-717. [PMID: 18440460 DOI: 10.1016/j.jvir.2008.01.016] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
71 Labori KJ, Schulz A, Drolsum A, Guren MG, Kløw NE, Bjørnbeth BA. Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center. Acta Radiol Open. 2015;4:2058460115580877. [PMID: 26346740 DOI: 10.1177/2058460115580877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
72 Petre EN, Sofocleous CT, Solomon SB. Ablative and catheter-directed therapies for colorectal liver and lung metastases. Hematol Oncol Clin North Am 2015;29:117-33. [PMID: 25475575 DOI: 10.1016/j.hoc.2014.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
73 Kuehl H, Stattaus J, Hertel S, Hunold P, Kaiser G, Bockisch A, Forsting M. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience. Clin Oncol (R Coll Radiol). 2008;20:234-240. [PMID: 18155453 DOI: 10.1016/j.clon.2007.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
74 Gotohda N, Nomura S, Doi M, Karasawa K, Ohki T, Shimizu Y, Inaba Y, Takeda A, Takaki H, Anai H, Ikeda M, Sugimoto M, Akimoto T. Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients. JGH Open 2020;4:722-8. [PMID: 32782962 DOI: 10.1002/jgh3.12325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Saxena A, Chua TC, Chu FC, Ng KM, Herle P, Morris DL. Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases. J Gastrointest Oncol 2014;5:46-56. [PMID: 24490042 DOI: 10.3978/j.issn.2078-6891.2013.055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Eng OS, Tsang AT, Moore D, Chen C, Narayanan S, Gannon CJ, August DA, Carpizo DR, Melstrom LG. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience. J Surg Oncol. 2015;111:410-413. [PMID: 25557924 DOI: 10.1002/jso.23849] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
77 van Amerongen MJ, Jenniskens SFM, van den Boezem PB, Fütterer JJ, de Wilt JHW. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. HPB (Oxford) 2017;19:749-56. [PMID: 28687147 DOI: 10.1016/j.hpb.2017.05.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
78 Nielsen K, Scheffer HJ, Pieters IC, van Tilborg AA, van Waesberghe JH, Oprea-Lager DE, Meijerink MR, Kazemier G, Hoekstra OS, Schreurs HW, Sietses C, Meijer S, Comans EF, van den Tol PM. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases. BMC Med Imaging. 2014;14:27. [PMID: 25103913 DOI: 10.1186/1471-2342-14-27] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
79 Aksoy E, Aliyev S, Taskin HE, Birsen O, Mitchell J, Siperstein A, Berber E. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases. Surgery 2013;154:748-52; discussion 752-4. [PMID: 24074411 DOI: 10.1016/j.surg.2013.05.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
80 Cacciola A, Parisi S, Tamburella C, Lillo S, Ferini G, Molino L, Iatì G, Pontoriero A, Bottari A, Mazziotti S, Cicero G, Minutoli F, Blandino A, Pergolizzi S. Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? Rep Pract Oncol Radiother 2020;25:299-306. [PMID: 32194349 DOI: 10.1016/j.rpor.2020.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Tsai S, Pawlik TM. Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges? Ann Surg Oncol 2009;16:2422-8. [PMID: 19554378 DOI: 10.1245/s10434-009-0491-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
82 Marchese U, Seux H, Garnier J, Ewald J, Piana G, Lelong B, Chaisemartin C, Meillat H, Delpero JR, Turrini O. Is percutaneous destruction of a solitary liver colorectal metastasis as effective as a resection? Ann Hepatobiliary Pancreat Surg 2021;25:198-205. [PMID: 34053922 DOI: 10.14701/ahbps.2021.25.2.198] [Reference Citation Analysis]
83 Mahnken AH, Pereira PL, de Baère T. Interventional oncologic approaches to liver metastases. Radiology 2013;266:407-30. [PMID: 23362094 DOI: 10.1148/radiol.12112544] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.0] [Reference Citation Analysis]
84 Stoltz A, Gagnière J, Dupré A, Rivoire M. Radiofrequency ablation for colorectal liver metastases. J Visc Surg 2014;151 Suppl 1:S33-44. [PMID: 24582728 DOI: 10.1016/j.jviscsurg.2013.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
85 Aliyev S, Agcaoglu O, Aksoy E, Taskin HE, Vogt D, Fung J, Siperstein A, Berber E. Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. Surgery. 2013;154:556-562. [PMID: 23859307 DOI: 10.1016/j.surg.2013.03.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
86 Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23-30. [PMID: 21435988 DOI: 10.1102/1470-7330.2011.0004] [Cited by in F6Publishing: 8] [Reference Citation Analysis]